Jubilant Ingrevia acquires 40% stake in Zettaone
Analysis based on 8 articles · First reported Aug 18, 2026 · Last updated Aug 19, 2026
The acquisition is expected to positively impact Jubilant Ingrevia's stock as it expands into the high-growth electronics and semiconductor value chain, potentially enhancing its long-term revenue and profitability. Zettaone Technologies, as an associate company, will benefit from Jubilant's manufacturing capabilities and customer relationships, likely boosting its growth prospects.
Jubilant Ingrevia, a specialty chemicals and CDMO company, has entered into a binding agreement to acquire a 40% strategic equity stake in Zettaone Technologies India, an electronics design and manufacturing platform, for Rs 189.2 crore (about $19.8 million). The acquisition will be completed in two tranches, with the first expected to close by November 2026 and the second by September 2027. Upon completion, Zettaone will become an associate company of Jubilant Ingrevia. The deal aligns with Jubilant's 'Pinnacle growth strategy' and provides a platform for its entry into the Electronics Development and Manufacturing Services (EDMS) space. Zettaone, founded by Harikrishnan Gopal, Sureshkumar Muthusamy, Prabu Murugan, and Arunkumar Muthusamy, offers end-to-end electronics product development for aerospace, defence, semiconductor, automotive, medical, and industrial applications. The acquisition will complement Jubilant's existing semiconductor chemicals business and strengthen its engagement with customers across the electronics and semiconductor value chain. Zettaone's revenue has grown from Rs 51.1 crore in FY24 to Rs 98.1 crore in FY26.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard